vasopressinase-altered vasopressin

amino acid sequence given in first source; may contribute to hypertension in transient diabetes insipidus of pregnancy; AVP ring has been opened between Cys and Tyr to produce a linear peptide

Also Known As:

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Toxemia 04/01/1990 - "The resulting molecule, vasopressinase altered vasopressin (VAV), may be present in greater concentration in preeclamptic women and over the months of the second trimester initiate the cascade of pathophysiologic changes resulting in toxemia."
2.	Pre-Eclampsia (Preeclampsia) 04/01/1990 - "A proposed relationship between vasopressinase altered vasopressin and preeclampsia."
3.	Diabetes Insipidus 03/01/1993 - "Transient diabetes insipidus of pregnancy (TDIP) is associated with elevated activity of vasopressinase, a plasma enzyme that opens the vasopressin (AVP) ring to produce a linear peptide that we have named vasopressinase-altered vasopressin (VAV). "

Related Drugs and Biologics

1.	Vasopressins (Vasopressin)
2.	Peptides (Polypeptides)
3.	Cystinyl Aminopeptidase
4.	Enzymes